Our Recommendations
- Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics (2022)
- Technology and Market Landscape Hepatitis C Medicines, August 2017 (2017)
- Prevención de la transmisión maternoinfantil del virus de la hepatitis B. Directrices sobre la profilaxis con antivirales en el embarazo (2020)
- Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection (2015)
- Guidelines on hepatitis B and C testing (2017)
New Publications
- Lignes directrices pour la prévention, le diagnostic, la prise en charge et le traitement des personnes atteintes d’une hépatite B chronique : note d’orientation (2024)
- Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection (March 2024) (2024)
- Guidance for country validation of viral hepatitis elimination and path to elimination (2023)
- Recommandations et orientations concernant l’autodépistage du virus de l’hépatite C (2021)
- WHO position paper on hepatitis A vaccines – October 2022 (2022)
Filter
42
Featured
Recommendations
8
New Publications
16
Language
Document type
Guidelines
17
No document type
16
Fact sheets
3
Manuals
2
Strategic & Response Plan
2
Studies & Reports
1
Videos
1
Countries / Regions
Global
2
Russia
2
Africa
1
Latin America and the Carribbean
1
South–East Asia Region
1
Argentina
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Toolboxes
Hepatitis
8
Paediatrics
3
Opportunistic Infections
2
Women
2
Prevention of mother-to-child transmission (PMTCT)
2
Adults
1
Prevention Guidelines
1
Policies
1
Transgender People
1
Men who have sex with men (MSM)
1
People who injecting Drugs
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Co-Morbidities (except TB)
1
HIV in Key Populations
1
Prisoners
1
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
WHO’s Dr Philippa Easterbrook gives a situation update on the recent hepatitis outbreak affecting children including possible causes and steps parents, caregivers and countries should take.
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
